IMPLANTABLE MESH

TheraMesh™

Prefabricated, bio-absorbable implantable mesh embedded with TheraSeed® or AgX100® for permanent implantation

Provides a flexible brachytherapy platform that may be contoured to implant surfaces
Low energy brachytherapy seeds with rapid dose fall off to minimize dose to normal structures
TheraSeed – Pd 103: 16.9 day half life; 20-23 keV principle energy
AgX100 – I 125: 59.4 day half life; 27-35 keV principle energy
An alternative delivery system for radiotherapy to tumor beds¹
May be suitable for anticipated close surgical margins and where other treatment options are limited¹
May be advantageous when the target volume is irregular and complex and critical normal structures are adjacent to the tumor implant²
Permanent implant allows for a higher total radiation dose to be delivered to the target volume²

¹Fairweather M, Wang, J, Devlin P, et al. Safety and efficacy of radiation dose delivered via Iodine-125 brachytherapy mesh implantation for deep cavity sarcomas. Ann Surg Oncol (2015) 22:1455–1463
²Devlin P, (ed), Brachytherapy Applications and Techniques, Second Edition, Demos Medical Publishing, LLC, New York, NY (2016)

TheraMesh is only approved for use in the U.S.A.